Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults
Clinical trial NCT00079820 · COMPLETED
Trial details
- NCT number
- NCT00079820
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2006-10-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.